METHOD FOR MANUFACTURING A MEASURING KIT AND METHOD FOR ACCELERATING AN ATTACHMENT OF AN ORGANIC MOLECULE TO A CARRIER

Abstract

A method for manufacturing a measuring kit is disclosed. The method for manufacturing a measuring kit includes steps of providing a carrier including a substrate having a surface; coating a silane onto the surface of the substrate; providing an organic molecule; adding the organic molecule onto the carrier; outputting a microwave energy by a coaxial cable; and emitting the microwave energy through a radiator to microwave the carrier and the organic molecule uniformly to coat the organic molecule onto the carrier carrying the silane, wherein the measuring kit is used to apply an enzyme-linked immunosorbent assay.

Claims

1-11. (canceled)

12. A method for accelerating an attachment of an organic molecule to a carrier, comprising steps of: providing the carrier including a substrate having a surface; coating a silane onto the surface of the substrate; adding the organic molecule onto the carrier; and increasing a collision probability between the carrier carrying the silane and the organic molecule with a specific power to accelerate the attachment of the organic molecule to the carrier carrying the silane.

13. The method according to claim 12, wherein the specific power is provided when a microwave energy is outputted by a coaxial cable and is uniformly emitted through a radiator to microwave the carrier carrying the silane and the organic molecule.

14. The method according to claim 12, wherein the organic molecule is one of an antibody and an antigen.

15. The method according to claim 12, wherein the specific power has a fixed value.

16. The method according to claim 15, wherein the carrier carrying the silane and the organic molecule are microwaved by a power less than 200 W.

17. The method according to claim 16, wherein the carrier carrying the silane and the organic molecule are microwaved by a power of 60 W for 30-40 minutes.

18. The method according to claim 12, wherein the carrier bears a plurality of spaced metal nanoparticles.

19. The method according to claim 12, wherein the carrier is one selected from a group consisting of a protein chip, a gene chip and a microchannel chip.

20. The method according to claim 12, wherein the substrate is made of one of a glass and a plastic.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0010] FIG. 1 shows comparison of coating transforming growth factor beta 1 (TGF-beta 1) overnight onto Corning's COR-9018 plate and coating TGF-beta 1 by microwaving in a microwave oven onto Corning's COR-9018 plate;

[0011] FIG. 2 shows comparison of coating TGF-beta 1 overnight onto Corning's COR-9018 plate and coating TGF-beta 1 by a microwave therapy apparatus onto Corning's COR-9018 plate;

[0012] FIGS. 3(a) and 3(b) show comparison of coating IL-15 by microwaving in a microwave oven onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and onto Corning's COR-9018 plate;

[0013] FIGS. 4(a) and 4(b) show comparison of coating TGF-beta 1 by microwaving in a microwave oven onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and onto Corning's COR-9018 plate;

[0014] FIG. 5 shows comparison of coating TGF-beta 1 overnight onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention;

[0015] FIGS. 6(a) and 6(b) show comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating TGF-beta 1 by a commercially available microwave oven onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention;

[0016] FIG. 7 shows comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating TGF-beta 1 by a microwave therapy apparatus onto Corning's COR-9018 plate;

[0017] FIGS. 8(a) and 8(b) show comparison of coating Interferon-gamma (IFN-gamma) by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating IFN-gamma by a microwave therapy apparatus onto Corning's COR-9018 plate;

[0018] FIGS. 9(a) and 9(b) show comparison of coating GM-CSF by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating GM-CSF by a microwave therapy apparatus onto Corning's COR-9018 plate;

[0019] FIGS. 10(a) and 10(b) show comparison of coating IL-12 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating IL-12 by a microwave therapy apparatus onto Corning's COR-9018 plate;

[0020] FIG. 11 shows comparison of coating tumor necrosis factor- (TNF-) by a microwave therapy apparatus at different times onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention;

[0021] FIG. 12 shows comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and onto a glass substrate carrier bearing silane of the present invention; and

[0022] FIG. 13 shows comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles of the present invention and onto a glass substrate carrier bearing silane of the present invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0023] The present invention will now be described more specifically with reference to the following embodiments. It is to be noted that the following descriptions of preferred embodiments of this invention are presented herein for the purposes of illustration and description only; they are not intended to be exhaustive or to be limited to the precise form disclosed.

[0024] The first embodiment of the present invention provides a method for manufacturing a measuring kit. The method for manufacturing a measuring kit includes steps of providing a carrier including a substrate having a surface; coating a silane onto the surface of the substrate; providing an organic molecule; adding the organic molecule onto the carrier; outputting a microwave energy by a coaxial cable; and emitting the microwave energy through a radiator to microwave the carrier and the organic molecule uniformly to coat the organic molecule onto the carrier carrying the silane, wherein the measuring kit is used to apply an enzyme-linked immunosorbent assay.

[0025] The carrier in this embodiment may be but is not limited to a chip, a strip or a plate. The chip may be a microarray or a lab-on-a-chip. The microarray may be but is not limited to a protein chip, a gene chip and a microchannel chip. The silane may be an alkylsilane, aminosilane or other silane. The aminosilane may be, for example, a 3-aminopropryltrimethoxysilane (APTMS) or 3-aminopropyltriethoxysilane (APTS). This embodiment may use any means or apparatus capable of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly. For example, a microwave therapy apparatus may be used, but is not limited thereto. In this embodiment, the carrier carrying the silane and the organic molecule may be microwaved by a power of less than 200 W. The microwaving step is more preferably performed under 60 W for 30-40 minutes, and the best is 60 W for 30 minutes.

[0026] The carrier in this embodiment may bears a plurality of spaced metal nanoparticles. The metal nanoparticles may be gold nanoparticles. The substrate of the carrier in this embodiment may be made of one of a glass and a plastic, and the glass may be an optical glass.

[0027] The enzyme-linked immunosorbent assay in this embodiment may be one selected from a group consisting of a sandwich enzyme-linked immunosorbent assay, an indirect enzyme-linked immunosorbent assay and a competitive enzyme-linked immunosorbent assay. The organic molecule may be one of an antibody and an antigen.

[0028] The second embodiment of the present invention provides a method for manufacturing a measuring kit. The method for manufacturing a measuring kit includes steps of providing a carrier including a substrate having a surface; coating a silane onto the surface of the substrate; providing an organic molecule; adding the organic molecule onto the carrier; outputting a microwave energy by a coaxial cable; and emitting the microwave energy through a radiator uniformly to microwave the carrier and the organic molecule to coat the organic molecule onto the carrier carrying the silane.

[0029] The carrier in this embodiment may be but is not limited to a chip, a strip or a plate. The chip may be a microarray or a lab-on-a-chip. The microarray may be but is not limited to a protein chip, a gene chip and a microchannel chip. The silane may be an alkylsilane, aminosilane or other silane. The aminosilane may be, for example, a 3-aminopropryltrimethoxysilane (APTMS) or 3-aminopropyltriethoxysilane (APTS). This embodiment may use any means or apparatus capable of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly. For example, a microwave therapy apparatus may be used, but is not limited thereto. In this embodiment, the carrier carrying the silane and the organic molecule may be microwaved by a power of less than 200 W. The microwaving step is more preferably performed under 60 W for 30-40 minutes, and the best is 60 W for 30 minutes.

[0030] The carrier in this embodiment may bear a plurality of spaced metal nanoparticles. The metal nanoparticles may be gold nanoparticles. The substrate of the carrier in this embodiment may be made of one of a glass and a plastic, and the glass may be an optical glass.

[0031] The measuring kit in this embodiment is used to apply to a measuring method. The measuring method may be one selected from a group consisting of a sandwich enzyme-linked immunosorbent assay, an indirect enzyme-linked immunosorbent assay and a competitive enzyme-linked immunosorbent assay. The organic molecule may be one of an antibody and an antigen.

[0032] The third embodiment of the present invention provides a method for accelerating an attachment of an organic molecule to a carrier is disclosed. The method for accelerating an attachment of an organic molecule to a carrier includes steps of providing the carrier including a substrate having a surface; coating a silane onto the surface of the substrate; adding the organic molecule onto the carrier; and increasing a collision probability between the carrier carrying the silane and the organic molecule with a specific power to accelerate the attachment of the organic molecule to the carrier carrying the silane.

[0033] The method for accelerating an attachment of an organic molecule to a carrier in this embodiment, wherein the specific power is provided when a microwave energy is outputted by a coaxial cable and is uniformly emitted through a radiator to microwave the carrier carrying the silane and the organic molecule. The specific power has a fixed value. The fixed value means that the specific power is kept constant and does not change with changes in voltage or current.

[0034] The carrier in this embodiment may be but is not limited to a chip, a strip or a plate. The chip may be a microarray or a lab-on-a-chip. The microarray may be but is not limited to a protein chip, a gene chip and a microchannel chip. The silane may be an alkylsilane, aminosilane or other silane. The aminosilane may be, for example, a 3-aminopropryltrimethoxysilane (APTMS) or 3-aminopropyltriethoxysilane (APTS). This embodiment may use any means or apparatus capable of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly. For example, a microwave therapy apparatus may be used, but is not limited thereto. In this embodiment, the carrier carrying the silane and the organic molecule may be microwaved by a power of less than 200 W. The microwaving step is more preferably performed under 60 W for 30-40 minutes, and the best is 60 W for 30 minutes.

[0035] The carrier in this embodiment may bear a plurality of spaced metal nanoparticles. The metal nanoparticles may be gold nanoparticles. The substrate of the carrier in this embodiment may be made of one of a glass and a plastic, and the glass may be an optical glass.

[0036] The method for accelerating an attachment of an organic molecule to a carrier in this embodiment is used to apply to a measuring method. The measuring method may be one selected from a group consisting of a sandwich enzyme-linked immunosorbent assay, an indirect enzyme-linked immunosorbent assay and a competitive enzyme-linked immunosorbent assay. The organic molecule may be one of an antibody and an antigen.

[0037] In a traditional enzyme-linked immunosorbent assay, coating proteins (antibodies or antigens) to plastic plate is mainly by standing. It uses electrostatic adsorption to coat the proteins on the surface of the plastic plate. Coating usually takes 12-18 hours and the time is too long. Therefore, the present invention provides a coating technique that outputs a microwave energy by a coaxial cable and emits the microwave energy through a radiator uniformly to solve the shortcomings of the disadvantage of the long coating time of the traditional enzyme-linked immunosorbent assay.

[0038] The principle of the present invention is to output a microwave energy by a way of a low-power coaxial cable and emit the microwave energy (<200 W) through a radiator uniformly to treat a coating buffer (containing proteins such as antibodies or antigens) in the carrier. This causes the water molecules in the coating buffer to oscillate at a frequency of 245 million times per second, resulting in an increase in the frequency of collisions between the protein molecules in the coating buffer, thereby increasing the collision probability between the protein molecules and the surface of the carrier, enabling the protein molecules to adsorb on the surface of the carrier in a short time, and the detection sensitivity is not reduced accordingly. In addition, the overall temperature of the carrier and the coating buffer in the invention after the microwave treatment only increases by about 3-4 degrees, which can prevent the protein molecules from denaturing due to the high temperature.

[0039] On the other hand, general commercially available microwave ovens use a magnetron to generate microwaves, and then use a waveguide to output microwaves to drive into a resonant cavity and perform microwave heating by a way of cavity resonance. Such a microwave energy output is likely to fluctuate with an external power supply. Therefore, the intensity of the microwave energy in the resonant cavity is directly affected, so that stable microwave power cannot be obtained. In addition, when the microwave oven is operating, the microwaves will form standing waves in the cavity, so the turntable needs to be continuously rotated so that the energy can be evenly distributed. However, it is still difficult to make the energy evenly distributed only by rotating the turntable. In the case of uneven microwave energy intensity received by the carrier, microwave coating using a microwave oven can only be performed for a short period of time, such as 20 seconds used in the present application, to avoid protein denaturation such as antibodies loss of activity. However, if the microwave time is too short, the coating effect is poor and the OD value is lower in the areas that receive less microwave energy intensity. Therefore, the use of microwave oven microwaves to coat protein molecules will lead to unstable experimental data and the OD value is relatively non-reproducible.

[0040] Therefore, according to the microwave coating used in the present invention, the microwave source feeds microwaves to a rectangular output plate (radiation probe) in a manner that a coaxial cable outputs microwave energy, and the size of the rectangular output plate (radiation probe) coincides with the 96-well plate, the two fit perfectly when microwaving, so every corner of the plate can be microwaved evenly. In addition, a stable microwave power output has the advantage of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly, and the negative feedback technology of a PID (proportional-integral-derivative control) can be designed to effectively ensure that the output microwave power does not fluctuate with external power supply fluctuations. Therefore, coating by using a way of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly can obtain stable experimental data.

[0041] Therefore, the method for manufacturing a measuring kit and the method for accelerating an attachment of an organic molecule to a carrier of the present invention using a way of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly greatly reduce the time required for the enzyme-linked immunosorbent assay, do not affect the detection sensitivity, and can obtain stable experimental data.

[0042] The ELISA in the experiments of the present invention is carried out by the following steps:

[0043] Solutions: [0044] Wash buffer-0.05% Tween 20 in Phosphate buffered saline (PBS) [0045] 5 Diluent-1% Bovine serum albumin (BSA) in PBS [0046] Substrate solution-1 TMB [0047] Stop Solution-2N H.sub.2SO.sub.4 [0048] 10 Coating buffer

[0049] Materials: [0050] Capture antibody: dilute 10 Coating buffer with ddH.sub.2O to 1 Coating buffer. Then dilute Capture antibody with 1 Coating buffer to 1 Capture antibody. [0051] Standard: dilute the target protein standard with 1 Diluent to the highest concentration, and then carry out serial dilution. [0052] Detection antibody: Detection antibody is diluted 250-fold with 1 Diluent to 1 Detection antibody. [0053] Avidin-HRP: Avidin-HRP is diluted 250-fold with 1 Diluent to 1 Avidin-HRP.

[0054] Process:

[0055] Step 1:

[0056] a. dilute capture antibody with 1 coating buffer, add 100 l/well of the diluted capture antibody to a glass/plastic strip or plate with/without gold nanoparticles and silane on the surface, seal the plate and stand the plate at 4 C. overnight (O/N).

[0057] b. coating by a commercially available microwave oven: capture antibody is diluted 250-fold with 1 coating buffer for the coating step. Add 100 l/well capture antibody to a glass/plastic strip or plate with/without gold nanoparticles and silane on the surface, microwave at 80 W for 20 seconds, and stand for 10 minutes at room temperature (replacing the traditional plate that needs to stand at 4 C. overnight).

[0058] c. coating by outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly: capture antibody is diluted 250-fold with 1 coating buffer for the coating step. Add 100 l/well capture antibody to a glass/plastic strip or plate with/without gold nanoparticles and silane on the surface, and microwave at 60 W for 30 minutes (replacing the traditional plate that needs to stand at 4 C. overnight).

[0059] Step 2: Wash the plate four times with Wash buffer of more than 250 l/well. Soak for 1 minute each time after washing, and flip down on the paper towel to remove residual liquid.

[0060] Step 3: Add 100 l/well of 1 Diluent and stand at room temperature for 1 hour.

[0061] Step 4: Wash the plate four times with Wash buffer of more than 250 l/well. Soak for 1 minute each time after washing, and flip down on the paper towel to remove residual liquid.

[0062] Step 5: Serially dilute the standard with 1 Diluent and add 100 l/well to the plate and stand at room temperature for 2 hours.

[0063] Step 6: Wash the plate four times with Wash buffer of more than 250 l/well. Soak for 1 minute each time after washing, and flip down on the paper towel to remove residual liquid.

[0064] Step 7: Dilute the Detection antibody with 1 Diluent, add 100 l/well and stand at room temperature for 1 hour.

[0065] Step 8: Wash the plate six times with Wash buffer of more than 250 l/well. Soak for 1 minute each time after washing, and flip down on the paper towel to remove residual liquid.

[0066] Step 9: Dilute Avidin-HRP with 1 Diluent, add 100 l/well, and stand in the dark for 30 minutes at room temperature.

[0067] Step 10: Wash the plate six times with Wash buffer of more than 250 l/well. Soak for 1 minute each time after washing, and flip down on the paper towel to remove residual liquid.

[0068] Step 11: Add 100 l/well TMB substrate and protect from light for 15 minutes for coloration.

[0069] Step 12: Add 50 l/well H.sub.2SO.sub.4 to stop the reaction.

[0070] Step 13: Use an ELASA analyzer to measure the results at 450 nm and correct the results at 630 nm.

[0071] Experiments

[0072] 1. Comparison of coating transforming growth factor beta 1 (TGF-beta 1) overnight onto Corning's COR-9018 plate and coating TGF-beta 1 by microwave in a microwave oven onto Corning's COR-9018 plate:

[0073] Please refer to FIG. 1 and Table 1. Use commercially available microwave oven to coat TGF-beta 1 onto Corning's COR-9018 plate (which is a commercially available plastic plate) by a power of 10% (about 80W) for 20 seconds. In the result, not only sensitivity is reduced but also OD values are decreased. Coating by microwaving in a microwave oven fails to improve the effectiveness of COR-9018 plate for coating TGF-beta 1.

TABLE-US-00001 TABLE 1 OD value Coating by Concentration Coating microwaving in a (pg/ml) overnight microwave oven 100 0.49930 0.162 10 0.06727 0.030 1 0.00688 0.002 0.1 0.00279 0.003 0.01 0.00163 0.003 0.001 0.00350 0.007

[0074] 2. Comparison of coating TGF-beta 1 overnight onto Corning's COR-9018 plate and coating TGF-beta 1 by a microwave therapy apparatus onto Corning's COR-9018 plate:

[0075] Please refer to FIG. 2 and Table 2. Use a microwave therapy apparatus to coat TGF-beta 1 onto Corning's COR-9018 plate (which is a commercially available plastic plate). In the result, not only sensitivity is reduced but also OD values are decreased. Coating by a microwave therapy apparatus fails to improve the effectiveness of COR-9018 plate for coating TGF-beta 1.

TABLE-US-00002 TABLE 2 OD value Coating by a Concentration Coating microwave (pg/ml) overnight therapy apparatus 1000 Exceed the 1.5040 measurable limit 100 0.9837 0.3166 10 0.1418 0.0442 1 0.0609 0.0185 0.1 0.0541 0.0158 0.01 0.0649 0.0170 Blank control 0.0613 0.0246 group

[0076] 3. Comparison of coating IL-15 by microwaving in a microwave oven onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and onto Corning's COR-9018 plate:

[0077] Please refer to FIG. 3(a), FIG. 3(b) and Table 3. Use commercially available microwave oven to coat IL-15 onto the carrier of the present invention and Corning's COR-9018 plate by a power of 10% (about 80W) for 20 seconds. After microwave coating, the sensitivity of IL-15 of the carrier of the present invention is 0.25 pg/ml, and the sensitivity of IL-15 of Corning's COR-9018 plate is 2.5 pg/ml. The sensitivity of the carrier of the present invention exceeds the traditional plate by more than 10 times.

TABLE-US-00003 TABLE 3 OD value The glass substrate carrier bearing gold nanoparticles and Concentration silane of the present (pg/ml) invention COR-9018 2500 Exceed the Exceed the measurable limit measurable limit 250 0.2821 0.2359 25 0.0277 0.0276 2.5 0.0207 0.0051 0.25 0.0168 0.0073

[0078] 4. Comparison of coating TGF-beta 1 by microwaving in a microwave oven onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and onto Corning's COR-9018 plate:

[0079] Please refer to FIG. 4(a), FIG. 4(b) and Table 4. Use commercially available microwave oven to coat TGF-beta 1 onto the carrier of the present invention and Corning's COR-9018 plate by a power of 10% (about 80W) for 20 seconds. After microwave coating using commercially available microwave, the best sensitivity of TGF-beta 1 of the carrier of the present invention can reach 0.001 pg/ml, and the sensitivity of TGF-beta 1 of Corning's COR-9018 plate is 10-1 pg/ml. After microwave coating by a commercially available microwave, the sensitivity of the carrier of the present invention exceeds the traditional plate by more than 10 times. However, due to the unstable output power of the microwave oven, the consistency of the OD value is not good.

TABLE-US-00004 TABLE 4 OD value Concentration The glass substrate carrier bearing gold (pg/ml) nanoparticles and silane of the present invention COR-9018 1000 2.7204 3.7078 1.5913 1.08807 Exceed the 2.1886 2.5786 measurable limit 100 0.3331 0.8055 0.5864 0.78117 1.05845 0.2908 0.4125 10 0.0466 0.0854 0.0744 0.11387 0.12495 0.0331 0.0444 1 0.0179 0.0193 0.0138 0.02018 0.02383 0.0022 0.0048 0.1 0.0062 0.0031 0.0131 0.01658 0.00959 0.0022 0.0013 0.01 0.0034 0.0003 0.0072 0.00638 0.006 0.0034 0.0002 0.001 0.0014 3.7E10 0.0032 0.00200 0.00341 0.0037 0.0002

[0080] 5. Comparison of coating TGF-beta 1 overnight onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating TGF-beta 1 by microwaving with a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention:

[0081] Please refer to FIG. 5 and Table 5. Coating TGF-beta 1 overnight and coating TGF-beta 1 by microwaving with a microwave therapy apparatus onto carriers bearing gold nanoparticles and silane of the present invention obtain similar OD values, and both reach sensitivity of 1 pg/ml.

TABLE-US-00005 TABLE 5 Concentration OD value (pg/ml) Coating overnight Coating by a microwave therapy apparatus 1000 2.3771 2.5472 Exceed the 3.470 Exceed the measurable measurable limit limit 100 0.4691 0.3902 0.8538 0.8984 0.6088 10 0.0839 0.0733 0.1400 0.1735 0.1343 1 0.0527 0.0428 0.07396 0.07416 0.0807 0.1 0.0485 0.0414 0.06580 0.06643 0.0735 0.01 0.0475 0.0397 0.06413 0.06232 0.068 Blank control 0.0426 0.0368 0.06051 0.06253 0.0604 group

[0082] 6. Comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating TGF-beta 1 by a commercially available microwave oven onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention:

[0083] Please refer to FIGS. 6(a), 6(b) and Table 6. Carry out microwave coating experiments using a microwave therapy apparatus and a commercially available microwave oven. Microwave condition of the commercially available microwave oven is 10% of power for 20 seconds. Microwave condition of the microwave therapy apparatus is 60 W for 30 minutes. As a result, regarding microwave coating data of the commercially available microwave oven, because microwave ovens use a magnetron to generate microwaves, and then use a waveguide to input microwaves into a resonant cavity through, such a microwave energy output way causes microwave energy to be unstable and makes the OD value less reproducible, and the experimental results are not stable. Using a microwave therapy apparatus, i.e. a way of outputting a microwave energy by a coaxial cable and emitting the microwave energy through a radiator uniformly, the output power is stable, and uniform microwaves can be provided to the carrier without being affected by the position of the sample on the carrier, and the obtained OD value is stable.

TABLE-US-00006 TABLE 6 OD value Concentration Commercially available (pg/ml) Microwave therapy apparatus microwave oven 100 0.597 0.6002 0.5701 0.9334 1.138 0.7701 10 0.1144 0.1156 0.1183 0.1226 0.1577 0.1113 1 0.07187 0.06281 0.05968 0.03501 0.07398 0.03680 0.1 0.06893 0.05742 0.05425 0.02383 0.05378 0.03045 0.01 0.06637 0.05560 0.05391 0.02286 0.05999 0.02919 Blank control 0.06581 0.06012 0.05381 0.02942 0.11584 0.03363 group

[0084] 7. Comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating TGF-beta 1 by a microwave therapy apparatus onto Corning's COR-9018 plate:

[0085] Please refer to FIG. 7 and Table 7. Microwave a carrier of the present invention and Corning's COR-9018 plate at 60 W for 30 minutes by a microwave therapy apparatus to coat TGF-beta 1. After coating by a microwave therapy apparatus, the best sensitivity of TGF-beta 1 of the carrier of the present invention can reach 0.1-0.01 pg/ml, and the sensitivity of TGF-beta 1 of Corning's COR-9018 plate is 10-1 pg/ml. After microwave coating by a microwave therapy apparatus, the sensitivity of the carrier of the present invention exceeds the traditional plate by more than 10 times, and the consistency of the OD value is good.

TABLE-US-00007 TABLE 7 OD value The glass substrate carrier bearing Concentration gold nanoparticles and silane of the (pg/ml) present invention COR-9018 1000 Exceed the 3.470 Exceed the 1.271 measurable limit measurable limit 100 0.8538 0.8984 0.9800 0.4936 10 0.1400 0.1735 0.1298 0.08029 1 0.07396 0.07416 0.04148 0.02764 0.1 0.06580 0.06643 0.03645 0.01943 0.01 0.06413 0.06232 0.04387 0.01921 Blank control 0.06051 0.06253 0.05533 0.02324 group

[0086] 8. Comparison of coating Interferon-gamma (IFN-gamma) by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating IFN-gamma by a microwave therapy apparatus onto Corning's COR-9018 plate:

[0087] Please refer to FIGS. 8(a), 8(b) and Table 8. After coating by a microwave therapy apparatus, the best sensitivity of IFN-gamma of the carrier of the present invention is 0.05 pg/ml, and the sensitivity of IFN-gamma of Corning's COR-9018 plate is 50-5 pg/ml. The sensitivity of the carrier of the present invention exceeds Corning's COR-9018 plate by more than 100 times.

TABLE-US-00008 TABLE 8 OD value The glass substrate carrier Concentration bearing gold nanoparticles and (pg/ml) silane of the present invention COR-9018 500 0.7406 1.501 50 0.2882 0.052 5 0.0739 0.0409 0.5 0.0574 0.0586 0.05 0.0485 0.0587

[0088] 9. Comparison of coating GM-CSF by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating GM-CSF by a microwave therapy apparatus onto Corning's COR-9018 plate:

[0089] Please refer to FIGS. 9(a), 9(b) and Table 9. After coating by a microwave therapy apparatus, the best sensitivity of GM-CSF of the carrier of the present invention can reach 0.0075 pg/ml, and the sensitivity of GM-CSF of Corning's COR-9018 plate is 0.075 pg/ml. The sensitivity of the carrier of the present invention exceeds Corning's COR-9018 plate by more than 10 times.

TABLE-US-00009 TABLE 9 OD value The glass substrate carrier bearing gold nanoparticles Concentration and silane of the present (pg/ml) invention COR-9018 750 2.782 3.634 75 0.182 0.217 7.5 0.016 0.014 0.75 0.013 0.004 0.075 0.005 0.002 0.0075 0.002 0.001 0.00075 -0.003 0.002

[0090] 10. Comparison of coating IL-12 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and coating IL-12 by a microwave therapy apparatus onto Corning's COR-9018 plate:

[0091] Please refer to FIGS. 10(a), 10(b) and Table 10. After coating by a microwave therapy apparatus, the best sensitivity of IL-12 of the carrier of the present invention can reach 0.005 pg/ml, and the sensitivity of IL-12 of Corning's COR-9018 plate is 0.5 pg/ml. The sensitivity of the carrier of the present invention exceeds Corning's COR-9018 plate by more than 100 times.

TABLE-US-00010 TABLE 10 OD value The glass substrate carrier bearing gold nanoparticles and Concentration silane of the (pg/ml) present invention COR-9018 500 Exceed the Exceed the Exceed the Exceed the measurable measurable measurable measurable limit limit limit limit 50 1.246 2.057 1.771 2.273681 5 0.264 0.278 0.222 0.347281 0.5 0.026 0.035 0.061 0.082051 0.05 0.022 0.020 0.004 0.103181 0.005 0.003 0.009 0.0003 0.044191

[0092] 11. Comparison of coating tumor necrosis factor- (TNF-) by a microwave therapy apparatus at different times onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention:

[0093] Please refer to FIG. 11 and Table 11. Microwave by a microwave therapy apparatus at different times, i.e. for 10, 15, 20, 25, 30, 35 and 40 minutes, respectively. The results show that the microwaving for 30 minutes can obtain the maximum linearity, achieve a better detection curve, space out the concentration detection range, and get the best results.

TABLE-US-00011 TABLE 11 TNF-alpha 10 15 20 25 30 35 40 (pg/ml) minutes minutes minutes minutes minutes minutes minutes 500 0.5843 0.5143 0.6321 0.4480 0.8289 0.7048 0.6248 50 0.1216 0.1257 0.1347 0.1088 0.1495 0.1549 0.1268 5 0.07072 0.06509 0.06718 0.06485 0.06767 0.07962 0.07701 0.5 0.06480 0.05875 0.06470 0.06315 0.06108 0.06748 0.07062 0.05 0.06334 0.05901 0.06051 0.06128 0.06126 0.06946 0.06817 0.005 0.06409 0.06038 0.06289 0.06213 0.06172 0.06724 0.06811 Blank 0.06198 0.06034 0.06202 0.06202 0.07127 0.05117 0.07040 control group Blank 0.06298 0.06228 0.04538 0.06346 0.06981 0.05117 0.07178 control group

[0094] 12. Comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles and silane of the present invention and onto a glass substrate carrier bearing silane of the present invention:

[0095] Please refer to FIG. 12 and Table 12. Compare a glass substrate carrier bearing gold nanoparticles and silane with a glass substrate carrier bearing silane after coating ten-fold diluted TGF-beta 1 standard by a microwave therapy apparatus. The overall OD values of the glass substrate carrier bearing gold nanoparticles and silane are higher, but after subtracting the background value, the glass substrate carrier bearing gold nanoparticles did not differ significantly from the glass substrate carrier bearing silane. After microwave coating by a microwave therapy apparatus, both of them can achieve good sensitivity.

TABLE-US-00012 TABLE 12 The glass substrate carrier Concentration bearing gold nanoparticles and The glass substrate carrier bearing (pg/ml) silane of the present invention silane of the present invention 1000 Exceed the 3.575 Exceed the Exceed the measurable limit measurable limit measurable limit 100 0.7612 0.7255 0.7280 0.7535 10 0.1483 0.1481 0.09843 0.09924 1 0.08253 0.07239 0.02227 0.02465 0.1 0.07399 0.06639 0.01655 0.01717 0.01 0.07599 0.06307 0.01674 0.01646 Blank control 0.07337 0.06284 0.01505 0.01659 group Blank control 0.07700 0.06322 0.01710 0.01672 group

[0096] 13. Comparison of coating TGF-beta 1 by a microwave therapy apparatus onto a glass substrate carrier bearing gold nanoparticles of the present invention and onto a glass substrate carrier bearing silane of the present invention:

[0097] Please refer to FIG. 13 and Table 13. Compare a glass substrate carrier bearing gold nanoparticles and silane with a glass substrate carrier bearing silane after coating five-fold diluted TGF-beta 1 standard by a microwave therapy apparatus. The overall OD values of the glass substrate carrier bearing gold nanoparticles and silane are higher, but after subtracting the background value, the glass substrate carrier bearing gold nanoparticles did not differ significantly from the glass substrate carrier bearing silane. After microwave coating by a microwave therapy apparatus, both of them can achieve good sensitivity.

TABLE-US-00013 TABLE 13 The glass substrate carrier The glass substrate bearing gold nanoparticles carrier bearing Concentration and silane of the silane of the (pg/ml) present invention present invention 1000 3.860 Exceed the 3.923 3.818 measurable limit 200 1.256 1.157 1.379 1.266 40 0.3055 0.2884 0.3076 0.3053 4 0.1175 0.1037 0.08846 0.07630 0.8 0.07916 0.06957 0.03338 0.03237 0.16 0.07154 0.06279 0.02192 0.02053 0.032 0.06608 0.05737 0.01938 0.01950 Blank control 0.06849 0.06165 0.02013 0.02013 group

Embodiments

[0098] 1. A method for manufacturing a measuring kit, comprising steps of: providing a carrier including a substrate having a surface; coating a silane onto the surface of the substrate; providing an organic molecule; adding the organic molecule onto the carrier; outputting a microwave energy by a coaxial cable; and emitting the microwave energy through a radiator to microwave the carrier and the organic molecule uniformly to coat the organic molecule onto the carrier carrying the silane, wherein the measuring kit is used to apply an enzyme-linked immunosorbent assay. [0099] 2. The method of Embodiment 1, wherein the microwaving step is performed under 60 W for 30-40 minutes. [0100] 3. The method of any one of Embodiments 1-2, wherein the carrier bears a plurality of spaced metal nanoparticles. [0101] 4. The method of any one of Embodiments 1-3, wherein the carrier is one selected from a group consisting of a protein chip, a gene chip and a microchannel chip. [0102] 5. A method for manufacturing a measuring kit, comprising steps of: providing a carrier including a substrate having a surface; coating a silane onto the surface of the substrate; providing an organic molecule; adding the organic molecule onto the carrier; outputting a microwave energy by a coaxial cable; and emitting the microwave energy through a radiator uniformly to microwave the carrier and the organic molecule to coat the organic molecule onto the carrier carrying the silane. [0103] 6. The method of Embodiment 5, wherein the microwaving step is performed under 60 W for 30-40 minutes. [0104] 7. The method of any one of Embodiments 5-6, wherein the microwaving step is performed under 60 W for 30 minutes. [0105] 8. The method of any one of Embodiments 5-7, wherein the carrier bears a plurality of spaced metal nanoparticles. [0106] 9. The method of any one of Embodiments 5-8, wherein the carrier is one selected from a group consisting of a protein chip, a gene chip and a microchannel chip. [0107] 10. The method of any one of Embodiments 5-9, wherein the substrate is made of one of a glass and a plastic. [0108] 11. The method of any one of Embodiments 5-10, wherein the measuring kit is applied to a measuring method being one selected from a group consisting of a sandwich enzyme-linked immunosorbent assay, an indirect enzyme-linked immunosorbent assay and a competitive enzyme-linked immunosorbent assay. [0109] 12. A method for accelerating an attachment of an organic molecule to a carrier, comprising steps of: providing the carrier including a substrate having a surface; coating a silane onto the surface of the substrate; adding the organic molecule onto the carrier; and increasing a collision probability between the carrier carrying the silane and the organic molecule with a specific power to accelerate the attachment of the organic molecule to the carrier carrying the silane. [0110] 13. The method of Embodiment 12, wherein the specific power is provided when a microwave energy is outputted by a coaxial cable and is uniformly emitted through a radiator to microwave the carrier carrying the silane and the organic molecule. [0111] 14. The method of any one of Embodiments 12-13, wherein the organic molecule is one of an antibody and an antigen. [0112] 15. The method of any one of Embodiments 12-14, wherein the specific power has a fixed value. [0113] 16. The method of any one of Embodiments 12-15, wherein the carrier carrying the silane and the organic molecule are microwaved by a power less than 200 W. [0114] 17. The method of any one of Embodiments 12-16, wherein the carrier carrying the silane and the organic molecule are microwaved by a power of 60 W for 30-40 minutes. [0115] 18. The method of any one of Embodiments 12-17, wherein the carrier bears a plurality of spaced metal nanoparticles. [0116] 19. The method of any one of Embodiments 12-18, wherein the carrier is one selected from a group consisting of a protein chip, a gene chip and a microchannel chip. [0117] 20. The method of any one of Embodiments 12-19, wherein the substrate is made of one of a glass and a plastic.

[0118] While the invention has been described in terms of what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention need not be limited to the disclosed embodiments. On the contrary, it is intended to cover various modifications and similar arrangements included within the spirit and scope of the appended claims which are to be accorded with the broadest interpretation so as to encompass all such modifications and similar structures.